CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

Foundation funds eleven new research projects. NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation® (LCRF) awarded its annual 2025 Scientific Grant Program ...

Tanea Brooks, best known as AEW wrestler Rebel, shared an update Monday as she continues to battle lung cancer. The ...

For both health systems and investors, the most exciting signal is how AI amplifies advances in biotechnology.

Dr. Albert Polito, the director of the Lung Center at the Mercy Medical Center, explained the signs that could mean a cough ...

Researchers say in future it may be possible to grow personalized organoids from patient’s own tissue, to test potential treatments in advance.

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.

For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and survivorship have created a new reality; lung cancer is treatable, survivable, and ...

Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...

November 2025 saw pivotal FDA approvals, including durvalumab for gastric cancers and pembrolizumab/enfortumab vedotin for ...

Lung cancer remains one of the most challenging diagnoses, but at St. Elizabeth Healthcare, new approaches to early detection ...